Pubblicazioni

The importance of right ventricular function in patients with pulmonary arterial hypertension.

2018 - Expert Rev Respir Med

Badagliacca, R; Papa, S; Poscia, R; Pezzuto, B; Manzi, G; Torre, R; Fedele, F; Vizza, Cd.

The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension. a meta-analysis

2018 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Vizza, C. D.; Badagliacca, R.; Messick, C. R.; Rao, Y.; Nelsen, A. C.; Benza, R. L.

Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension. clinical and haemodYnamic long-term efficacy (ITALY study)

2018 - JOURNAL OF CARDIOVASCULAR MEDICINE

D'alto, M.; Romeo, E.; Argiento, P.; Paciocco, G.; Prediletto, R.; Ghio, S.; Correale, M.; Lo Giudice, F.; Badagliacca, R.; Greco, A.; Vizza, C. D.

Dobutamine stress echocardiography in pulmonary arterial hypertension

2018 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Ghio, S.; Fortuni, F.; Greco, A.; Turco, A.; Lombardi, C.; Scelsi, L.; Raineri, C.; Matrone, B.; Vullo, E.; Guida, S.; Badagliacca, R.; Oltrona Visconti, L.

Initial combination therapy for patients with pulmonary arterial hypertension (PAH). a budget impact analysis from the perspective of the italian national healthcare system

2018 - EXPERT OPINION ON ORPHAN DRUGS

Barbieri, M.; Ghio, S.; D'Alto, M.; Albera, C.; Carignola, R.; Mule, M.; Vitulo, P.; Vighini, M.; Silvestri, R.; Zamboni, W.; Vizza, C. D.